Skip to main content
. 2022 Jan 23;10(2):176. doi: 10.3390/vaccines10020176

Table 2.

Summary of parameters sourced for the model.

Parameter Value Source
Percentage of 65+ population vaccinated 54.7% [17]
Life expectancy for 65+ population 9.8 years [18]
65+ population size 9,371,743 [19]
aQIV tender price EUR 13 [44]
aQIV list price EUR 23 [45]
HD-QIV tender price EUR 25 [44]
HD-QIV list price EUR 32 [45]
Primary-care physician visits cost EUR 59 [46,47,48]
Emergency department visit cost EUR 183 [46,47,48]
Hospitalization cost EUR 4467 [47,49]
Comedication cost EUR 3.21 [50]
Probability of being employed (65–69 years old) 1.2% [52]
Probability of being employed (75+ years old) 0.3% [52]
Productivity loss per hour EUR 17.44 [53]
Probability of requiring care at home (65–69 years old) 5.4% [54]
Probability of requiring care at home (75+ years old) 14% [54]
Baseline utility for 65+ 0.65 [23]
Disutility value for symptomatic patients 0.32 [43]
Disutility value for outpatients 0.33 [42]
Disutility value for inpatients 0.6 [42]
Disutility duration for symptomatic patients 7 days [43]
Disutility duration for outpatients 7 days [42]
Disutility duration for inpatients 21 days [42]
Hospital mortality rate for 65+ population 6% [24]
Discount rates for costs and outcomes 3% [16]